How HPLC and Mass Spectrometry Verify Peptide Identity in a Research Laboratory

The two analytical techniques that anchor every legitimate peptide release are high-performance liquid chromatography (HPLC) and mass spectrometry (MS). They answer two different questions about a vial of synthetic compound: How pure is it? and Is it actually the molecule on the label? Neither question has anything to do with human or animal use — they are the gatekeepers of analytical research integrity.

HPLC: Quantifying Purity

Reversed-phase HPLC separates a peptide from synthesis-related impurities — truncated sequences, deletion peptides, oxidized methionines, racemized residues, and residual solvents. The standard configuration for peptide analysis is:

Column — C18 silica, 4.6 × 250 mm, 5 µm particle size
Mobile phase A — water + 0.1% trifluoroacetic acid (TFA)
Mobile phase B — acetonitrile + 0.1% TFA
Gradient — typically 5% to 65% B over 30 minutes
Detection — UV at 214 nm (peptide bond absorbance) and often 280 nm (Trp/Tyr)

A research-grade peptide release criterion of ≥ 99% area purity means that when the chromatogram is integrated, the main peak accounts for at least 99% of the total UV absorbance. Anything less indicates measurable impurities — often from incomplete coupling reactions during solid-phase synthesis.

This is the same technique that Merrifield’s original 1963 paper on solid-phase peptide synthesis (Journal of the American Chemical Society, 85:2149) eventually enabled at scale. Modern UHPLC systems reduce the analysis to 5–10 minutes per sample without sacrificing resolution.

Mass Spectrometry: Confirming Identity

HPLC tells you a peak is clean. Mass spectrometry tells you what that peak is. The two most common methods for peptide identification:

ESI-MS (electrospray ionization) — Peptide is sprayed from solution into the source as multiply-charged ions [M+H]⁺, [M+2H]²⁺, [M+3H]³⁺. The m/z values are deconvoluted to the neutral monoisotopic mass.
MALDI-TOF — Peptide is co-crystallized with a matrix (α-cyano-4-hydroxycinnamic acid or sinapinic acid) on a target plate, then ionized by laser pulse. Time-of-flight separation gives mass directly.

Worked examples from common research peptides:

BPC-157 — calculated monoisotopic mass 1418.71 Da. Acceptance window ±0.5 Da.
TB-500 (Thymosin β-4 fragment) — calculated 4961.51 Da. ESI-MS typically reports the [M+4H]⁴⁺ peak at m/z 1241.39.
Semaglutide — calculated 4113.58 Da. Multi-charge envelope from m/z 823.7 ([M+5H]⁵⁺) down to m/z 1372.2 ([M+3H]³⁺).
GHK-Cu — Gly-His-Lys + Cu²⁺. Free GHK calculated 340.18 Da; the copper complex shifts by +61.93 Da.

What an Honest COA Reports

A Certificate of Analysis from a serious research supplier should list, at minimum:

Compound name and amino acid sequence
Molecular formula and calculated mass
Observed mass from MS, with method (ESI or MALDI)
HPLC purity percentage with chromatographic conditions
Net peptide content (corrects for water and counterions — typically 70–90% of the lyophilized mass for TFA salts)
Batch number and date of analysis
Signature or initials of the analytical chemist

What a COA does not include — because it is not relevant to laboratory research use — is sterility data, endotoxin levels, USP/EP compendial monographs, or dosing recommendations. Those are pharmaceutical-grade specifications and are not produced for research lots.

Why This Documentation Has Scientific Value

Published in-vitro work depends on traceable starting material. When Sikiric’s laboratory reports a BPC-157 dose-response in a tendon healing model, the manuscript’s methods section will cite the supplier, batch, HPLC purity, and MS confirmation. Reviewers expect this. A peptide without analytical documentation cannot be used in publishable research — the data would not pass peer review.

This is why Chempeptides releases compounds against HPLC and MS criteria and makes the COA available per batch. It is the document that tells a laboratory chemist: this material is what it says it is, to the precision the literature requires.

The Standard Released by Chempeptides

HPLC purity ≥ 99% by area at 214 nm
Mass spectrometry identity confirmed within 0.5 Da of calculated
Net peptide content reported on the COA
Batch traceability from synthesis through release

This is research-supply work. It exists to support analytical method development, receptor binding assays, cell-based pharmacology, and the broader peptide literature — none of which involves human or animal consumption.

For laboratory and analytical research only. Not for human consumption, animal consumption, or therapeutic use. Certificates of Analysis available per batch on request.

Blogs